G-202 in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Prostate Cancer

NCT02381236 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: G-202

Sponsor

GenSpera, Inc.